Based on the Wall Street analyst consensus for 50 of DE:GN0M’s holdings.
DE:GN0M 12 Month Forecast
Average Price Target
$13.80â–²(32.31% Upside)
Based on Wall Street analyst 12-month price targets for 50 of Global X Genomics & Biotechnology UCITS ETF’s holdings in the last 3 months. The average price target is $13.80 with a high forecast of $18.93 and a low forecast of $9.05. The average price target represents a 32.31% change from the last price of $10.43.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$18.93
Average$13.80
Low$9.05
Past 12 Months12 Month Forecast$5$8.5$12$15.5$19Feb2026May2026Aug2026Nov2026Nov2027
What is DE:GN0M’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 50 of DE:GN0M’s holdings, Global X Genomics & Biotechnology UCITS ETF’s 12-month average price target is $13.80.
What is DE:GN0M’s upside potential, based on the analysts’ average price target?
DE:GN0M’s average price target of $13.80 represents a 32.31% upside from its last price of $10.43.
Is DE:GN0M a Buy, Sell or Hold?
Global X Genomics & Biotechnology UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 50 of DE:GN0M’s holdings: 40 rated Buy, 9 rated Hold and 1 rated Sell.
What is Global X Genomics & Biotechnology UCITS ETF’s price target?
The average price target for Global X Genomics & Biotechnology UCITS ETF is $13.80, based on Wall Street analyst 12-month price targets for 50 of DE:GN0M’s holdings, issued in the past 3 months. The highest price target is $18.93 and the lowest is $9.05. The average price target represents a 32.31% increase from the last price of $10.43.
What is DE:GN0M’s expense ratio?
DE:GN0M’s expense ratio is 0.50%.
How many holdings does DE:GN0M have?
DE:GN0M holds 51 assets.
How can I buy shares of DE:GN0M?
You can buy shares of DE:GN0M through a brokerage account. Compare brokers on our Best Online Brokers page.